Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...
This week Novartis NVS upgraded its mid-term sales growth guidance. The European Commission approved Pfizer’ s PFE hemophilia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback